Literature DB >> 2583567

Comparison of albendazole, mebendazole and praziquantel chemotherapy of Echinococcus multilocularis in a gerbil model.

D H Taylor1, D L Morris, D Reffin, K S Richards.   

Abstract

The efficacy of albendazole (50 mg/kg/d), mebendazole (50 mg/kg/d) and praziquantel (500 mg/kg/d) against established intraperitoneal infections of Echinococcus multilocularis in gerbils was compared by monitoring parasite weight and making ultrastructural observations on treated and untreated material. Praziquantel was the most active protoscolicidal agent, reducing protoscolex viability to less than 2%, although it did not inhibit cyst growth. Albendazole was the most effective agent in reducing cyst growth and was, when compared with other regimes significantly more effective than mebendazole (p less than 0.05), praziquantel (p less than 0.01) or untreated controls (p less than 0.01).

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2583567      PMCID: PMC1434421          DOI: 10.1136/gut.30.10.1401

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  12 in total

1.  Echinococcus multilocularis: in vivo results of therapy with albendazole and praziquantel.

Authors:  D H Taylor; D L Morris; K S Richards; D Reffin
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

2.  New aspects in the management of alveolar echinococcosis involving the liver.

Authors:  R Schröder; G Robotti
Journal:  World J Surg       Date:  1986-12       Impact factor: 3.352

3.  Chemotherapy of experimental echinococcosis.

Authors:  J Eckert; B Burkhardt
Journal:  Acta Trop       Date:  1980-09       Impact factor: 3.112

4.  Mebendazole and alveolar hydatid disease.

Authors:  J F Wilson; R L Rausch
Journal:  Ann Trop Med Parasitol       Date:  1982-04

5.  Consequences of continuous mebendazole therapy in alveolar hydatid disease--with a summary of a ten-year clinical trial.

Authors:  R L Rausch; J F Wilson; B J McMahon; M A O'Gorman
Journal:  Ann Trop Med Parasitol       Date:  1986-08

6.  Multicentre clinical trials of benzimidazolecarbamates in human echinococcosis.

Authors:  A Davis; Z S Pawlowski; H Dixon
Journal:  Bull World Health Organ       Date:  1986       Impact factor: 9.408

7.  Echinococcus granulosus: the effects of praziquantel, in vivo and in vitro, on the ultrastructure of equine strain murine cysts.

Authors:  K S Richards; D L Morris; D Daniels; E M Riley
Journal:  Parasitology       Date:  1988-04       Impact factor: 3.234

8.  Albendazole therapy in alveolar hydatid disease: a report of favorable results in two patients after short-term therapy.

Authors:  J F Wilson; R L Rausch; B J McMahon; P M Schantz; D E Trujillo; M A O'Gorman
Journal:  Am J Trop Med Hyg       Date:  1987-07       Impact factor: 2.345

9.  In vitro culture of Echinococcus multilocularis: protoscolicidal action of praziquantel and albendazole sulphoxide.

Authors:  D H Taylor; D L Morris
Journal:  Trans R Soc Trop Med Hyg       Date:  1988       Impact factor: 2.184

10.  Human echinococcosis: follow-up of 23 patients treated with mebendazole.

Authors:  P Kern
Journal:  Infection       Date:  1983 Jan-Feb       Impact factor: 3.553

View more
  9 in total

1.  Efficacies of albendazole sulfoxide and albendazole sulfone against In vitro-cultivated Echinococcus multilocularis metacestodes.

Authors:  K Ingold; P Bigler; W Thormann; T Cavaliero; B Gottstein; A Hemphill
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

Review 2.  Tropical medicine.

Authors:  G C Cook
Journal:  Postgrad Med J       Date:  1991-09       Impact factor: 2.401

3.  The effect of combination therapy with albendazole and praziquantel on hydatid cyst treatment.

Authors:  Mahin Jamshidi; Minou Mohraz; Mehrangiz Zangeneh; Ali Jamshidi
Journal:  Parasitol Res       Date:  2008-06       Impact factor: 2.289

4.  Identification of Functional MKK3/6 and MEK1/2 Homologs from Echinococcus granulosus and Investigation of Protoscolecidal Activity of Mitogen-Activated Protein Kinase Signaling Pathway Inhibitors In Vitro and In Vivo.

Authors:  Chuanshan Zhang; Jing Li; Tuerganaili Aji; Liang Li; Xiaojuan Bi; Ning Yang; Zhide Li; Hui Wang; Rui Mao; Guodong Lü; Yingmei Shao; Dominique A Vuitton; Hao Wen; Renyong Lin
Journal:  Antimicrob Agents Chemother       Date:  2018-12-21       Impact factor: 5.191

5.  Disseminated abdominal hydatidosis: a rare presentation of common infectious disease.

Authors:  Abdulrahman Almalik; Aynaa Alsharidi; Mohammed Al-Sheef; Mushirah Enani
Journal:  Case Rep Infect Dis       Date:  2014-07-08

6.  Albendazole increases the inflammatory response and the amount of Em2-positive small particles of Echinococcus multilocularis (spems) in human hepatic alveolar echinococcosis lesions.

Authors:  Franz J Ricken; Juliane Nell; Beate Grüner; Julian Schmidberger; Tanja Kaltenbach; Wolfgang Kratzer; Andreas Hillenbrand; Doris Henne-Bruns; Peter Deplazes; Peter Moller; Peter Kern; Thomas F E Barth
Journal:  PLoS Negl Trop Dis       Date:  2017-05-25

7.  Medical treatment for an isolated renal multilocular hydatid cyst in an elderly: a case report.

Authors:  Atie Moghtadaie; Seyed Amir Miratashi Yazdi; Minoo Mohraz; Hoda Asefi; Effat Razeghi
Journal:  BMC Nephrol       Date:  2020-10-08       Impact factor: 2.388

8.  Albendazole reduces hepatic inflammation and endoplasmic reticulum-stress in a mouse model of chronic Echinococcus multilocularis infection.

Authors:  Michael Weingartner; Simon Stücheli; Fadi Jebbawi; Bruno Gottstein; Guido Beldi; Britta Lundström-Stadelmann; Junhua Wang; Alex Odermatt
Journal:  PLoS Negl Trop Dis       Date:  2022-01-14

9.  Abdominal wall hydatid cyst: case report and review of literature.

Authors:  V Abhishek; Vijayraj S Patil; Ullikashi Mohan; B S Shivswamy
Journal:  Case Rep Surg       Date:  2012-08-16
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.